BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Technical Sentiment
Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.47, suggesting BridgeBio Oncology Therapeutics is a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 9.36, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 10.20, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
8.21
8.53
8.71
9.03
9.21
9.53
9.71
Fibonacci
8.53
8.72
8.84
9.03
9.22
9.34
9.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
8.95Sell
8.90Sell
MA10
8.97Sell
9.03Sell
MA20
9.38Sell
9.36Sell
MA50
10.49Sell
10.20Sell
MA100
11.42Sell
10.79Sell
MA200
11.09Sell
10.84Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 9.03, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 10.79, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 10.49, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 11.42, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 11.09, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
37.72
Neutral
STOCH (9,6)
37.82
Neutral
STOCHRSI (14)
18.28
Buy
MACD (12,26)
-0.47
Sell
ADX (14)
16.00
Buy
Williams %R
-90.66
Buy
CCI (14)
-90.02
Neutral
ATR (14)
0.61
-
Ultimate Oscillator
36.14
Neutral
ROC
-14.82
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 37.72, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 16.00, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -90.02, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -14.82, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Strong Sell.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 37.72, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.47, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 8.95, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 9.38, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 10.49, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 11.09, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -90.66, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -90.02, which suggests BBOT is a Neutral.